2014 to 2023 Saw Rise in Pediatric PCP Visits With Mental Health Issues

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 21, 2026.

via HealthDay

THURSDAY, May 21, 2026 -- Pediatric primary care physician (PCP) visits with mental health (MH) issues increased from 2014 to 2023 in Massachusetts, according to a research letter published online May 18 in JAMA Network Open.

Kerrin M. Gallagher, Ph.D., M.P.H., from the Boston University School of Public Health, and colleagues estimated temporal trends in pediatric primary care visits that included MH issues using all-payer data from Massachusetts in a cohort study. The study sample included 37,659,240 person-quarters, representing 1,848,249 unique children aged 1 to 18 years.

The researchers observed an increase in the rate of PCP visits with any MH diagnosis, from 5.9 visits per 100 children in quarter 1 of 2014 to 9.7 visits per 100 children in quarter 1 of 2023. The absolute changes were greatest for PCP visits for anxiety (from 1.7 to 6.1 percent of PCP visits). For other diagnosis types, there were also increases seen in the percentage of PCP visits with MH diagnoses from quarter 1 of 2014 to quarter 1 of 2023, although they were smaller in magnitude, including for attention-deficit/hyperactivity disorder (from 5.0 to 6.7 percent), depression (from 1.2 to 1.6 percent), autism spectrum disorder (from 0.5 to 2.0 percent), and trauma and stressor-related disorders (from 0.8 to 1.6 percent). The total number of all-cause PCP visits decreased slightly when population-level rates of PCP use were examined, from 58.9 to 54.8 visits per 100 children.

"Observed trends may reflect increases in the underlying prevalence of pediatric MH needs alongside increases in PCP capacity to screen for and address MH needs," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords